Dr. Nur Kusaira is a dedicated plant biotechnology researcher with a deep passion for unlocking the therapeutic and nutritional potential of plant natural products. Her academic journey began with a Bachelor's degree in Plant Resource Science and Management from Universiti Malaysia Sarawak (UNIMAS) in 2008, majoring in Plant Systematics. She was awarded the Best Undergraduate Thesis that year. She went on to earn a Master's in Healthcare Biotechnology from Universiti Sains Malaysia (USM), where she focused on in silico screening of phytocompounds against H5N1 and H1N1 influenza viruses under the supervision of Prof. Dr. Habibah Abd Wahab. In 2012, she undertook a research attachment at UC San Diego, where she conducted molecular dynamics simulations of plant-based inhibitors targeting the NS2B/NS3 protein of Dengue virus type 2 (DENV-2). Her career then led her to Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), where she managed the USM-RIKEN natural product discovery grant, working on the development of a comprehensive library of Malaysian plant extracts intended for diverse bioactivity screenings, laying the groundwork for systematic exploration of Malaysia’s phytochemical biodiversity. Though initially set to pursue her PhD at USM, Dr. Nur Kusaira was awarded an international PhD scholarship by Universiti Malaya and joined the University of Copenhagen, Denmark, under Prof. Dr Henrik Toft Simonsen. Her PhD work made headlines in plant synthetic biology, she pioneered the use of Physcomitrella patens for stable in vivo assembly of biosynthetic gene clusters, achieving the first stable plant-based production of artemisinin, a vital antimalarial drug, marking a breakthrough in sustainable pharmaceutical production. Her research continues at the intersection of plant science, biotechnology, and health. She focuses on: Functional Food Innovation: Developing plant-based bioactives with nutraceutical properties for preventive health and wellness. Drug Discovery: Leveraging computational tools to identify potent, selective plant-based inhibitors targeting cancer, viral and microbial proteins. Plant Synthetic Biology: Exploring plant platforms like moss and medicinal species for scalable biosynthesis of valuable therapeutic molecules. Dr. Nur Kusaira’s work reflects a commitment to sustainability, global health, and innovation paving the way for plant-derived therapeutics that are effective, affordable, and accessible worldwide.

Dr. Noorhayati Idros holds a Bachelor’s degree (Hons.) in Electrical & Electronics Engineering from Universiti Tenaga Nasional, Malaysia, and an M.Sc. in Nanoelectronics from The University of Manchester, United Kingdom. Her M.Sc. research at Manchester focused on the fabrication of polymer-based thin-film transistors (OTFTs), examining the effects of elevated temperatures on OTFT performance and the active layer's morphology. Following her M.Sc., Dr. Idros joined the Centre for Photonic Devices and Sensors Group at Cambridge University’s Department of Engineering as a Ph.D. candidate. Her doctoral research centered on developing biochemical sensors to detect water contaminants, specifically targeting explosives like 2,4,6-trinitrotoluene (TNT) and heavy metals. This interdisciplinary work utilized aptamer/DNA and chemically functionalized nanophotonic crystal surfaces, integrating microfluidics paper-based devices, sensitive optical detection, and systematic colorimetric analysis in RGB-space via digital imaging and color calibration. Her sensors were designed for low-cost, portable applications. Dr. Idros is an alumnus of Corpus Christi College, University of Cambridge (UCAM), and was active in university sports, serving as netball team captain for the Cambridge University Malaysia Society and as a netball player for the Malaysian Students' Society of Manchester. Upon completing her Ph.D., Dr. Idros continued as a Postdoctoral Research Associate at the Cavendish Laboratory, Cambridge, where she developed fluorescence-based biochemical sensors for detecting heavy metals in water for Peruvian environmental projects. She also conducted environmental quality assessments in the Rio Cañete drainage basin, using Andean River Shrimp as a bioindicator species. This work involved DNA barcoding for species identification and dietary analysis of the shrimp. Dr. Idros also trained university staff and students in laboratory and field methods, presented her findings, and contributed to the PERU-UCAM staff and student exchange program. In addition to her academic accomplishments, Dr. Idros brings significant industry experience from her time as an engineer at Intel Microelectronics Sdn. Bhd., where she supported System Windows Hardware Quality Labs (WHQL) testing for Vista and XP PV milestones, executed CPU and platform test plans, and led Vista Debug installations for CPU Product Release Qualification (PRQ). She also contributed to the Mobile Internet Device (MID) project and gained expertise in Linux-based application porting, as well as electrical and electronics debugging. Currently, Dr. Idros is a Senior Lecturer in the Department of Electrical Engineering at Universiti Malaya and a Core Member of the Centre of Printable Electronics, specializing in the development of nanotechnology-based sensors for water quality and environmental monitoring. 

Associate Professor Dr. Chen Yeng is an expert in cancer biomarker discovery, biosensor development, and natural therapeutics, with a multidisciplinary approach that bridges nanotechnology, molecular biology, and biomedicine. Her expertise is particularly evident in her work on innovative diagnostic technologies and personalized therapeutic solutions, targeting both cancer and infectious diseases.  Her research interests span several cutting-edge areas. One of her primary focuses is the identification and characterization of cancer biomarkers, particularly through novel approaches targeting at immunogenic host proteins. This line of research explores how immunogenic proteins’ interventions might modulate cancer risk, representing an innovative intersection of microbiology, proteomics, and oncology.  Dr. Chen is also deeply engaged in developing advanced diagnostic tools, including nanobiosensors with enhanced sensitivity and specificity. These devices, designed to detect critical biomarkers such as those associated with tuberculosis, blood clotting disorders, and oral cancer, are transformative for early disease detection. Her work in biosensors, utilizing materials like gold nanoparticles and zinc oxide nanolayers, has set new standards in diagnostic accuracy and reliability.  Another cornerstone of her research is the study of natural plant extracts for therapeutic applications, particularly in cancer treatment. She investigates the biochemical and pharmacological properties of these extracts, focusing on their mechanisms of action, such as inducing apoptosis, causing cell cycle arrest, and promoting mitochondrial dysfunction in cancer cells. Her exploration of natural products' roles in modulating microRNAs further highlights her innovative approach to cancer research.  Dr. Chen’s expertise also extends to the antioxidant, hepatoprotective, and genoprotective properties of herbal compounds, offering potential preventive and therapeutic solutions for chronic diseases. These studies underline her commitment to sustainable and natural approaches in healthcare.  Her contributions to genomics and proteomics, particularly in large-scale screening for biological markers, further demonstrate her role as a leader in translating complex biological data into meaningful clinical applications. By combining her deep understanding of molecular biology with a focus on real-world impact, Dr. Chen has established herself as a pioneer in her field.  Dr. Chen’s academic influence is demonstrated by her impressive h-index of 28 (ResearchID) and 39 (Scopus), with over 4,500 citations to her name. Her extensive publication record spans high-impact journals, contributing significantly to advancements in dentistry, oncology, and biomedical engineering. She is recognized as a top scientist in Malaysia, ranking among the leading figures in dentistry according to the AD Scientific Index. As a respected peer reviewer for prestigious journals, including Coordination Chemistry Reviews, Periodontal 2000, Biosensors and Bioelectronics, and Cancer Letters, Dr. Chen plays a critical role in maintaining the quality of research within her fields of expertise. Her contributions extend to academic leadership, where she had supervised and graduated over 20 postgraduate students, including 11 PhD candidates, nurturing the next generation of scientific leaders. Her leadership in dental education accreditation has further solidified her impact on academic excellence. She has played pivotal roles in the reaccreditation of dental programs at the University of Malaya and other institutions, ensuring that these programs meet global standards. Through her commitment to interdisciplinary collaboration, Dr. Chen has partnered with industry leaders to translate research findings into practical healthcare solutions, such as rapid diagnostic tools and personalized treatments. These collaborations exemplify her ability to bridge scientific discovery with real-world applications. In summary, Dr. Chen’s expertise and research interests reflect a holistic approach to biomedical science, integrating cutting-edge technologies with sustainable practices. Her work not only pushes the boundaries of knowledge in cancer research and diagnostics but also has the potential to transform patient care and public health globally.